Moderate Alcohol Intake Among Patients With Type 2 Diabetes

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 109 participants.

Also called NCT00295334

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 109 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT00295334
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT00295334. Randomized; single masking; primary purpose prevention. Start 2010-06 (registry gives no type); primary completion 2012-05 (actual). Results posted on 2025-06-24.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Moderate Alcohol Intake Among Patients With Type 2 Diabetes
Intervention (Drug)
alcohol
Lead sponsor
Iris Shai (class: other)
Collaborator
The Israeli Diabetes Research Group (class: not stated)
Collaborator
Hadassah Medical Organization (class: other)
Collaborator
Soroka University Medical Center (class: other)
Collaborator
Julio Vainstein, Wolfson Medical Center, Holon, Israel (class: not stated)
Collaborator
Tishbi Wines, Israel and Admiral Wine Imports, US (class: not stated)
Collaborator
Harvard University (class: other)

Record details

Record id
cardio:ct-nct00295334
Content hash
4fd350862489b16b906105c4296c7f0a7b24ab155cd533c41c460ea3f9171a37